Fig. 5From: ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancerGene set enrichment analysis. The enriched pathways included (A) DNA repair, (B) MYC targets V2, (C) MYC targets V1, (D) KRAS signaling up, (E) Epithelial mesenchymal transition, (F) Complement, (G) Inflammatory response, (H)Â IL2/STAT5 signaling pathwayBack to article page